Filing Details

Accession Number:
0001600620-24-000021
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-02-22 16:33:06
Reporting Period:
2024-02-20
Accepted Time:
2024-02-22 16:33:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1600620 Aurinia Pharmaceuticals Inc. AUPH Pharmaceutical Preparations (2834) 981231763
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1938159 Michael Scott Habig #140, 14315-118 Avenue
Edmonton A0 T5L 4S6
Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-02-20 195,512 $0.00 508,231 No 4 A Direct
Common Stock Disposition 2024-02-20 15,867 $5.48 492,364 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Footnotes
  1. Represents grant of Restricted Stock Units (RSUs) payable solely in common stock of the Issuer that vest in three (3) equal annual installments on the first, second and third anniversary of the grant date.
  2. Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of RSUs granted on August 1, 2022 grant.